NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 130 filers reported holding NOVAVAX INC in Q2 2017. The put-call ratio across all filers is 1.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $108,000 | +671.4% | 57,603 | +425.3% | 0.00% | – |
Q4 2017 | $14,000 | -88.6% | 10,965 | -89.9% | 0.00% | -100.0% |
Q3 2017 | $123,000 | -55.3% | 108,390 | -54.7% | 0.01% | -54.5% |
Q2 2017 | $275,000 | +108.3% | 239,245 | +837.9% | 0.01% | +37.5% |
Q1 2016 | $132,000 | – | 25,508 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parametrica Management Ltd | 61,882 | $438,000 | 2.76% |
BB BIOTECH AG | 8,330,000 | $58,893,000 | 1.87% |
Cormorant Asset Management, LP | 1,600,000 | $11,312,000 | 1.81% |
HARVEY CAPITAL MANAGEMENT INC | 623,950 | $4,411,000 | 1.76% |
WILLIAM HARRIS INVESTORS INC | 488,666 | $3,455,000 | 0.98% |
Eventide Asset Management | 2,097,500 | $14,829,000 | 0.86% |
AWM Investment Company, Inc. | 400,000 | $2,828,000 | 0.55% |
NORTHPOINTE CAPITAL LLC | 507,344 | $3,587,000 | 0.47% |
Rock Springs Capital Management LP | 715,000 | $5,055,000 | 0.41% |
Opus Point Partners Management, LLC | 100,000 | $707,000 | 0.39% |